Last updated at 06 Nov 2025 08:18 AM
Director
DIN: 09092419
Shraddhaben Gautambhai Vaghasiya is currently associated with 2 companies in various capacities such as Director and Individual Subscriber. They serve as a Director at DHRUV REMEDIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09092419.Shraddhaben Gautambhai Vaghasiya is currently involved in 2 different roles. Their most recent position is with DHRUV SPECIALITY CHEM PRIVATE LIMITED as a Individual Subscriber. The first company Shraddhaben Gautambhai Vaghasiya was appointed to as a director was DHRUV REMEDIES PRIVATE LIMITED. Shraddhaben Gautambhai Vaghasiya is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Shraddhaben Gautambhai Vaghasiya is currently associated with 2 companies in various capacities such as Director and Individual Subscriber. They serve as a Director at DHRUV REMEDIES PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 09092419.Shraddhaben Gautambhai Vaghasiya is currently involved in 2 different roles. Their most recent position is with DHRUV SPECIALITY CHEM PRIVATE LIMITED as a Individual Subscriber. The first company Shraddhaben Gautambhai Vaghasiya was appointed to as a director was DHRUV REMEDIES PRIVATE LIMITED. Shraddhaben Gautambhai Vaghasiya is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1 Year 6 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| DHRUV REMEDIES PRIVATE LIMITED | Director | 04-Mar-2021 |
| DHRUV SPECIALITY CHEM PRIVATE LIMITED | Individual Subscriber | 21-May-2025 |